Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease
Active, not recruiting
- Conditions
- Alzheimer Disease
- Interventions
- Other: Cognitive Assessment
- Registration Number
- NCT05379348
- Lead Sponsor
- AdventHealth Translational Research Institute
- Brief Summary
The purpose of this study is to investigate how we can detect Alzheimer's disease early by using an online memory test and a simple blood test. These new methods for early diagnosis could allow people to begin treatment sooner, with the potential to improve the lives of millions of people.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 1423
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description General study participants (patients) Cognitive Assessment -
- Primary Outcome Measures
Name Time Method Quantify the proportion of individuals at least 65 years old with cognitive impairment Less than 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
AdventHealth Translational Research Institute
🇺🇸Orlando, Florida, United States